.png)
.png)
Principal Scientist
Merck & Co., Inc.
Disclosure(s): Merck and Co.: Stocks/Bonds
Julie Strizki, PhD, is a Principal Scientist in Infectious Disease and Vaccines at Merck and Co. She currently serves as a Clinical Virolgist, supporting several early and late stage antiviral programs including, molnupiravir; letermovir, raltegravir, and the MK-1654 RSV surveillance program. Prior to her current position, she focused her research work on early drug discovery of novel agents to treat HIV and other viruses.
.